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ttp://dx.doi.org/10.1016/j.ajpath.2014.12.008Fibrosis is a multicellular process leading to excessive extracellular matrix deposition. Factors that affect
lung epithelial cell proliferation and activation may be important regulators of the extent of ﬁbrosis after
injury. We and others have shown that activated alveolar epithelial cells (AECs) directly contribute to
ﬁbrogenesis by secreting mesenchymal proteins, such as type I collagen. Recent evidence suggests that
epithelial cell acquisition of mesenchymal features during carcinogenesis and ﬁbrogenesis is regulated
by several mesenchymal transcription factors. Induced expression of direct inhibitors to these mesen-
chymal transcription factors offers a potentially novel therapeutic strategy. Inhibitor of DNA-binding 2
(Id2) is an inhibitory helix-loop-helix transcription factor that is highly expressed by lung epithelial cells
during development and has been shown to coordinate cell proliferation and differentiation of cancer
cells. We found that overexpression of Id2 in primary AECs promotes proliferation by inhibiting a reti-
noblastoma protein/c-Abl interaction leading to greater c-Abl activity. Id2 also blocks transforming
growth factor b1emediated expression of type I collagen by inhibiting Twist, a prominent mesenchymal
basic helix-loop-helix transcription factor. In vivo, Id2 induced AEC proliferation and protected mice
from lung ﬁbrosis. By using a high-throughput screen, we found that histone deacetylase inhibitors
induce Id2 expression by adult AECs. Collectively, these ﬁndings suggest that Id2 expression by AECs can
be induced, and overexpression of Id2 affects AEC phenotype, leading to protection from ﬁbrosis.
(Am J Pathol 2015, 185: 1001e1011; http://dx.doi.org/10.1016/j.ajpath.2014.12.008)Funded by NIH grants R01 HL108904-01 (K.K.K.) and HL108794
(P.J.W.), the Martin E. Galvin Fund (K.K.K.), and the Nina Ireland Pro-
gram for Lung Health (P.J.W.).
Disclosures: None declared.Tissue ﬁbrosis is characterized by matrix remodeling and
changes in the cellular makeup.1e4 Injury leads to epithelial
cell apoptosis and a damaged, denuded basement mem-
brane.5,6 There is rapid replacement with a provisional
matrix and variable accumulation of monocytes and in-
ﬂammatory cells. Finally, there is recruitment of activated
myoﬁbroblasts and deposition of ﬁbrotic matrix proteins,
such as type I collagen.
Although there has been considerable focus on myoﬁ-
broblast activation, ﬁbrogenesis is clearly a multicellular
process.4,7 Injury induces activation of resident structural
cells, including epithelial cells, endothelial cells, and peri-
cytes, which functionally contribute in unique and over-
lapping ways to the developing ﬁbrosis.4,7 Epithelial cells
are abundant in the lung, and their response during injury
and repair is an important determinant toward eitherstigative Pathology.
.restoration of homeostasis or progressive ﬁbrosis.8 Epithe-
lial cells can produce matrix proteins, including laminins
and collagens. Epithelial cell apoptosis and proliferation are
both prominent features of ﬁbrotic tissue. Finally, epithelial
cells produce several proﬁbrotic and antiﬁbrotic factors that
inﬂuence the behavior of neighboring cells. Thus, epithelial
cell production of basement membrane matrix proteins,
proliferation and differentiation of epithelial stem cells, and
production of antiﬁbrotic factors may favor restoration of
the lung to homeostasis, whereas epithelial cell death or
acquisition of mesenchymal features with production of
Yang et alﬁbrotic matrix proteins and cytokines may initiate and
sustain ﬁbrosis. These phenotypic changes are regulated, in
part, at a transcriptional level.
Recent evidence suggests that phenotypic changes within
epithelial cells during carcinogenesis and ﬁbrogenesis are
regulated by several mesenchymal transcription factors.
Suppressed expression of these epithelial-mesenchymal
transition transcription factors for therapeutic intervention9
is under investigation, but at least one family of epithelial-
mesenchymal transition transcription factors has a natural
set of direct inhibitory factors. Thus, induced expression of
these inhibitory factors offers a potential alternative
approach.
Helix-loop-helix (HLH) transcription factors, most notably
Twist, E2A (with splice variants E47 and E12), and E2-2, have
been implicated in cancer cell acquisition of mesenchymal
features, including migration and invasion.10e14 Twist has
also been shown to be up-regulated in epithelial cells and ﬁ-
broblasts in lung tissue from patients with idiopathic pulmo-
nary ﬁbrosis (IPF).15,16 The functional signiﬁcance of HLH
transcription factors toﬁbrogenesis, however, remains unclear.
HLH transcription factors function as heterodimers and
homodimers, which directly bind to DNA.17 Class V HLH
transcription factors, made up of a family of inhibitor of DNA-
binding (Id) proteins, lack a DNA-binding basic domain and
inhibit DNA binding by other HLH factors.18
Overexpression of Id1 and Id2, in particular, has been
shown to inhibit cancer cell mesenchymal gene expression
and invasion.19,20 In addition to its interaction with basic
HLH transcription factors, a novel interaction between Id2
and retinoblastoma protein (Rb), a member of the pocket
protein family, was identiﬁed and demonstrated to be
important for epithelial cell proliferation.21,22 Most studies
have focused on Rb acting as an inhibitor of Id2-mediated
proliferation, but the downstream events of this inhibitory
interaction have not been identiﬁed. Finally, Id2 has
emerged as a prominent marker of lung epithelial cells
during lung development, with absent or low-level Id2
expression in the adult lung epithelial cells.23,24
More important, expression of the Ids can be regulated by
extracellular factors suggesting that transcriptional pro-
gramming by basic HLH factors can be regulated. Trans-
forming growth factor b1 (TGFb1), a prominent cytokine in
cancer and ﬁbrosis biology, is the most well-studied repressor
of Id expression.12 Conversely, signaling through bone
morphogenetic proteins and Wnt/b-catenin has been shown
to stimulate Id expression in several cell types.12 Regulation
of Id expression has mostly been studied in cancer cells and
during development. Regulation of Id2 expression by pri-
mary adult alveolar epithelial cells (AECs) and its down-
stream effects have not been well studied. Herein, we ﬁnd
that overexpression of Id2 inhibits activated primary AEC
production of type I collagen through an interaction with
Twist. Id2 promotes AEC proliferation on basement mem-
brane proteins through a novel Rb-cAbl pathway leading to
inhibition of ﬁbrosis. Finally, by using Id2 promoteregreen1002ﬂuorescent protein (GFP) reporter mice to screen a library of
chemical compounds, we found that histone deacetylase in-
hibitors have the ability to induce Id2 expression in adult
AECs.
Materials and Methods
Mice
All mice were in a C57bl/6 background. Mice with
enhanced GFP (eGFP) insertion into the Id2 locus (Id2-
eGFP) were from Jackson Laboratory (Bar Harbor, ME).23
Floxed Twist mice were from the Mutant Mouse Regional
Resource Center.25 Surfactant protein-C promoterereverse
tetracycline transactivator and tetO-CMV promotereCre
recombinase mice were previously described.26 Mice aged 6
to 8 weeks were intratracheally (IT) injected with 50 mL
saline or 1.5 U/kg bleomycin.27 Mice were anesthetized and
intranasally given adenovirus expressing GFP (AdGFP) or
Id2 (AdId2) at 4  108 plaque-forming units (PFU) per
mouse on day 9 after bleomycin.26 Bronchial alveolar
lavage ﬂuid and lung samples were collected for analysis,
as previously described.28,29 Mice were bred and main-
tained in a speciﬁc pathogen-free environment. All animal
experiments were approved by the University Animal
Care and Use Committee at the University of Michigan
(Ann Arbor, MI).
Antibodies and Other Reagents
Fibronectin (Fn) and antibodies to prosurfactant protein-C
and glyceraldehyde-3-phosphate dehydrogenase are from
Millipore (Billerica, MA). Matrigel (Mg), biotin-conjugated
rat anti-mouse CD16/32, and CD45 antibodies were from
BD Biosciences (Franklin Lakes, NJ). Other antibodies used
in this study included collagen I and Twist (Abcam, Cam-
bridge, MA), Id2 and connective tissue growth factor (Santa
Cruz Biotechnology, Santa Cruz, CA), pS807/811 Rb, pS795
Rb, pS780 Rb, Rb, cAbl, pCrkL, and CrkL (Cell Signaling,
Beverly, MA). Recombinant keratinocyte growth factor was
from PeproTech (Rocky Hill, NJ). Small airway growth
medium was from Lonza (Walkersville, MD). 5-Ethynyl-20-
deoxyuridine (EdU) was from Life Technologies (Grand
Island, NY). Imatinib, nalotinib, MS275, and trichostatin A
(TSA) were from Sigma-Aldrich (St. Louis, MO).
Type II AEC Isolation and Culture
Murine type II AECs were isolated and cultured in small
airway growth medium with keratinocyte growth factor at
10 ng/mL on tissue culture plates that were precoated with
either Mg or Fn, as previously described.28,29 Brieﬂy, mouse
lungs were exposed for perfusion and lavage after sacriﬁce.
Isolated lungs were digested with dispase for 45 minutes
and then dissected. Lungs were treated with DNase for 10
minutes, and then serially ﬁltered through 70-, 40-, andajp.amjpathol.org - The American Journal of Pathology
Id2 Prevents Fibrosis20-mm ﬁlters. Resuspended cells were labeled with biotin-
conjugated anti-CD16/32 and anti-CD45 at 37C for 30
minutes. Cells were negatively selected with streptavidin-
conjugated magnetic beads through a magnetic separator.
AECs were further negatively selected by incubating for 1
to 2 hours on a plastic plate.
For primary human AECs, written informed consent was
obtained from all subjects and the study was approved by
the University of California, San Francisco, and University
of Michigan Institutional Review Boards. IPF lung tissues
were obtained from explanted lung from patients with a
pathological diagnosis of usual interstitial pneumonia and a
consensus clinical diagnosis of IPF on the basis of histol-
ogy, physical examination, high-resolution computed to-
mography, pulmonary function testing, and diagnostic lung
biopsy. Human type II AECs were isolated, as previously
described,27,30 from explanted IPF lungs or human lungs not
used by the Northern California Transplant Donor Network;
our studies indicate that these lungs are physiologically and
pathologically normal.31 Brieﬂy, dispase-digested lung was
mined and then sequentially ﬁltered through nylon mesh.
Filtered cells were separated using a Percoll density gradient
(Sigma, St. Louis, MO). Contaminating macrophages were
negatively selected with anti-CD14 magnetic beads and
adherence to human IgG-coated plates. Type II AECs were
further puriﬁed by cell sorting for the EpCAM-positive,
CD45-negative, T1a-negative fraction of nonadherent cells.
Adenoviral and Lentiviral Infection of Cells
Expression vector to generate AdId2 was generated by
PCR and cloning of murine Id2 into pAd5CMVmcsIR-
ESeGFPpA using standard cloning techniques. Adenovirus
was generated by the University of Iowa (Iowa City, IA)
Gene Transfer Vector Core. AECs were treated with
AdGFP, AdId2, or adenovirus expressing Cre recombinase
at 50 PFU/cell for 2 consecutive days. After additional 24 or
48 hours, cells were lysed for analysis. For Id2 knockdown,
the RNA interference vectors were purchased from Open-
Biosystems (GE Healthcare, Lafayette, CO), and lentivirus
was generated by the University of Michigan Vector Core.
Lentivirus (5 PFU/cell) was used on days 2 and 3 after AEC
isolation to inhibit expression of Id2 in primary mouse
AECs.
Luciferase Assay
E2F activity was determined using the Cignal Reporter System
(Qiagen, Valencia, CA). Lentivirus encoding ﬁreﬂy luciferase
regulated by E2F response element and CMV-renilla lucif-
erase was used to treat AECs, followed by treatment with
AdGFP or AdId2. After 2 additional days, ﬁreﬂy luciferase
normalized to renilla luciferase was determined using a Dual
Luciferase Assay System (Promega, Madison, WI) and a
Veritas microplate luminometer (Turner Biosystems, Madi-
son, WI), per manufacturers’ protocol.The American Journal of Pathology - ajp.amjpathol.orgDNA Synthesis Assay and EdU Staining
Cell proliferation was determined by two different DNA
synthesis assays. 3H-thymidine was added to cells 18 to 24
hours before harvest at the time points indicated. Prolifer-
ation was read as counts per minute on a LS6500 scintil-
lation counter (Beckman Coulter, Brea, CA), as previously
described.32 For some experiments, chemical inhibitors
were added to the cell culture media at physiologically
relevant doses previously reported to fully inhibit the tar-
geted pathways.33e43 Abl kinase inhibitors, imatinib at 10
mmol/L and nalotinib at 1 mmol/L, or dimethyl sulfoxide
(DMSO) control was added to cells 48 hours before harvest.
For the Id2 knockdown experiment, mouse primary AECs
were isolated and cultured on Mg-coated 6-well plates. Cells
were treated with lentivirus to knock down Id2 expression
on days 2 and 3, and then the cells were treated with 100
nmol/L histone deacetylase inhibitors TSA, 50 mmol/L
MS275, or DMSO control on day 4. 3H-thymidine was
added on day 5, and cells were harvested on day 6.
For EdU in vitro staining, EdU was added to cells at the
ﬁnal concentration of 10 mmol/L 2 hours before harvest.
Cells were ﬁxed in 3.7% formaldehyde diluted in
phosphate-buffered saline for 15 minutes. After washing,
cells were permeabilized in phosphate-buffered saline with
0.5% Triton X-100 (Sigma) for 20 minutes. Cells were
stained using Click-iT reaction cocktail (Invitrogen, Grand
Island, NY). For EdU in vivo staining, EdU was adminis-
tered by i.p. injection to mice at 25 mg/g of body weight 24
hours before sacriﬁce. Lung tissues were embedded in OCT
compound and frozen immediately after isolation in dry ice.
An immunoﬂuorescence staining protocol was followed for
EdU and other protein detection.
Hematoxylin and Eosin Staining and Masson’s
Trichrome Assay
Mice were dissected to harvest lung tissues for staining, as
previously described.28,29 Lungs were inﬂated with form-
aldehyde to 25 cm H2O pressure. Lungs were embedded in
parafﬁn, divided into sections, and stained by the McClin-
chey Histology Laboratory (Stockbridge, MI).
Hydroxyproline Assay
Lung hydroxyproline was measured as described previ-
ously.28,29 Brieﬂy, mouse lungs were isolated and homog-
enized at 3 weeks after bleomycin IT injection and AdGFP/
AdId2 intranasal administration. Homogenized lungs were
baked in 12N HCl overnight at 120C. The samples were
mixed with citrate buffer and chloramine T and incubated at
room temperature for 30 minutes. Erlich’s solution was then
added, and the samples were incubated at 65C for another
15 minutes. The absorbance at 540 nm was measured and
the hydroxyproline concentration was quantiﬁed against
hydroxyproline standards.1003
Yang et alImmunoﬂuorescence Staining
Immunoﬂuorescence was performed on mouse lung cry-
osections (7 mm thick), as described before.28,29 Stained
sections were imaged on an Olympus BX-51 ﬂuorescence
microscope (Olympus, Tokyo, Japan), and images were
captured with an Olympus DP-70 camera (Olympus) and
analyzed with DP controller software version 3.1.1.267
(Olympus).
Gene Expression Analysis
Gene expression was analyzed by quantitative RT-PCR, as
described before.28,29 Brieﬂy, mouse primary AECs were
lysed in 1 mL TRIzol (Life Technologies). Reverse tran-
scription was performed with the SuperScript III ﬁrst-strand
synthesis kit (Invitrogen), and RT-PCR was performed
using the POWER SYBR Green PCR MasterMix Kit
(Applied Biosystems, Grand Island, NY) on Applied Bio-
systems 7000 sequence detection system or Life Technol-
ogies ViiA7 Real Time PCR System. The fold changes were
normalized to the housekeeping controls b-actin and glyc-
eraldehyde-3-phosphate dehydrogenase. Primer sequences
for gene collagen 1a1, collagen 3a1, Fn, connective tissue
growth factor, b-actin, and glyceraldehyde-3-phosphate
dehydrogenase were described previously.28,29 Other
primer sequences were as follows: Twist1, 50-CGCACG-
CAGTCGCTGAACG-30 (forward) and 50-GACGCGGA-
CATGGACCAGG-30 (reverse); proliferating cell nuclear
antigen, 50-GGAGAGCTTGGCAATGGGAAC-30 (forward)
and 50-CAGGTACCTCAGAGCAAACGT-30 (reverse); Rb,
50-CGATACCAGTACCAAGGTTG-30 (forward) and 50-GC-
ACTGCTGGGTTGTGTCAA-30 (reverse); murine Id2, 50-
AGCCTGCATCACCAGAGACCT-30 (forward) and 50-CG-
ACATAAGCTCAGAAGGGAA-30 (reverse); E2A, 50-TTCT-
CCTCCCGCTTGATCTC-30 (forward) and 50-AGTTCCC-
TCCCTGACCTCTCA-30 (reverse); E12, 50-GTGGCCGT-
CATCCTCAGC-30 (forward) and 50-GCTGCTTTGGGGT-
TCAGG-30 (reverse); E47, 50-GCCGAAGAGGACAAGAA-
GG-30 (forward) and 50-CTTCTCCTCCAGGGACAGC-30
(reverse); E2-2, 50-TTGAACCCACCCCAAGACCC-30
(forward) and 50-CGCCCTCGTCATCGGATTTG-30
(reverse); and human Id2, 50-GAACTGCAGTTTTAA-
TGGGCAGGAGATGC-30 (forward) and 50-GGAAAG-
CTTCAGTGCAAGGTAAGTGATGG-30 (reverse).
Immunoprecipitation and Immunoblot Analysis
AECs were lysed in radioimmunoprecipitation assay with
phosphatase inhibitor cocktail (Calbiochem, Billerica, MA).
After centrifuging, the supernatants were precleared with pro-
tein Aeagarose beads, then incubatedwith 5mg of antibodies to
Id2, cAbl, or an appropriate control IgG at 4C for 1 hour. The
samples were then incubated with 50 mL of protein Aeagarose
at 4C overnight. The immunocomplexes were washed three
times in 1% Triton X-100. The immunoprecipitates were eluted1004by boiling the beads, and the supernatants were collected for
immunoblotting. Immunoblot analysis of cells or immuno-
precipitates was performed as previously described.26,27
Scanned immunoblots are representative of at least three
separate experiments.
High-Throughput Screening
High-throughput screening was performed with the Center
for Chemical Genomics Core Facility (University of
Michigan). Primary AECs from Id2-eGFP mice were iso-
lated and cultured on Mg-coated 384-well plates. After 24
hours, medium was replaced and supplemented with
chemical compounds listed in Supplemental Table S1. After
an additional 48 hours, cells were resuspended with Cell
Recovery Solution (BD Biosciences) and analyzed for GFP
expression using a Hypercyt/Accuri: High Throughput Flow
Cytometer combination system (BD Biosciences) enabling
multiplex ﬂow cytometry. The ﬂow cytometry data were
analyzed with FloJo software version 10 (Ashland, OR) for
expression of GFP.
Statistical Analysis
Data are expressed as means, and error bars indicate SEM.
For evaluation of group differences, the two-tailed Student’s
t-test was used, assuming equal variance. P < 0.05 was
accepted as signiﬁcant.
Results
Overexpression of Id2 Inhibits AEC Activation and
Induces Proliferation in Vitro
We have previously shown that primary AECs cultured on
Mg, which is rich in basement membrane proteins, proliferate
and maintain an AEC phenotype, whereas AECs cultured on
Fn, a provisional matrix protein, lose epithelial markers and
have increased expression of ﬁbrotic matrix and matricellular
proteins through integrin-mediated endogenous TGFb1 acti-
vation.26 Cultured AECs from WT mice were infected with
adenovirus encoding murine Id2 (AdId2, 50 PFU/cell) or
control adenovirus expressing GFP (AdGFP) to induce
overexpression of Id2 (Supplemental Figure S1). Over-
expression of Id2 signiﬁcantly attenuated Fn-mediated AEC
up-regulation of several mesenchymal markers by real-time
quantitative PCR and immunoblot (Figure 1, A and B). On
Mg, Id2 overexpression signiﬁcantly increased proliferation
of cultured primary AECs as determined by incorporation of
a thymidine analogue, EdU, and by 3H-thymidine incorpo-
ration assay (Figure 1, CeF). Similarly, primary human
AECs treated with AdId2 also demonstrated reduced
expression of ﬁbrotic mesenchymal proteins when cultured
on Fn and showed increased proliferation when cultured on
Mg (Figure 1, GeI). As expected, AECs from IPF lungs had
similar expression of Id2 compared to normal human AECsajp.amjpathol.org - The American Journal of Pathology
Figure 1 Overexpression of inhibitor of DNA-
binding 2 (Id2) suppresses alveolar epithelial cell
(AEC) activation and stimulates proliferation. A and
B: Primary murine AECs immediately after isolation
(initial) or cultured on ﬁbronectin (Fn) for 4 days
and treated with adenovirus expressing GFP
(AdGFP) or Id2 (AdId2). Overexpression of Id2 in-
hibits expression of proﬁbrotic genes by real-time
quantitative PCR (A) and immunoblot (B). CeE:
5-Ethynyl-20-deoxyuridine (EdU) incorporation of
AECs cultured on Matrigel (Mg) for 4 days and
treated with AdGFP (C) or AdId2 (D). E: AECs treated
with AdId2 have greater percentage of EdU-positive
cells per 100 ﬁeld. F: AECs cultured on Mg and
treated with AdGFP or AdId2. After 2 to 8 days, cells
were analyzed by 3H-thymidine incorporation,
demonstrating increased proliferation in AECs
overexpressing Id2 on days 2, 4, and 6. G: Over-
expression of Id2 inhibits proﬁbrotic protein
expression by primary human AECs cultured on
Fn for 4 days compared to cells treated with AdGFP.
H: Human AECs cultured on Mg and treated AdId2
have increased proliferation after 2 days compared
to the cells treated with AdGFP determined by
3H-thymidine incorporation. I: AECs from idio-
pathic pulmonary ﬁbrosis (IPF) lungs have similar
levels of Id2 gene expression compared to normal
human AECs (P Z 0.34). n Z 4 (A, E, F, and H);
nZ 15 (I). *P < 0.05 compared to AdGFP-treated
cells (E); *P < 0.05 compared to AdGFP-treated
cells at the same time point (F); *P < 0.05 (H);
**P < 0.01 (A). Col, collagen; CCN2, connective
tissue growth factor; GAPDH, glyceraldehyde-3-
phosphate dehydrogenase.
Id2 Prevents Fibrosis(n Z 15, P Z 0.34). We next determined if induced over-
expression of Id2 could attenuate ﬁbrosis.
Overexpression of Id2 Attenuates Fibrosis and Induces
AEC Proliferation in Vivo
AEC proliferation and ﬁbrotic matrix production have both
been implicated as important determinants of the extent of
lung ﬁbrosis after injury.8 WT mice were given either IT
saline or bleomycin. Ten days after bleomycin treatment,
mice were given a single dose of AdGFP or AdId2 (4  108
per mouse), leading to robust overexpression of GFP or Id2
primarily within AECs for at least 2 weeks after adenovirus
treatment (data not shown). At day 21 after bleomycin, mice
were analyzed for ﬁbrosis by trichrome staining and hy-
droxyproline. Mice treated with AdId2 have signiﬁcantly
less bleomycin-induced ﬁbrosis compared to mice treated
with bleomycin and control adenovirus (Figure 2, AeC).
Mice treated with saline and AdGFP or AdId2 are histo-
logically normal (Supplemental Figure S2). In separate ex-
periments, proliferation was assessed in vivo by IP injectionThe American Journal of Pathology - ajp.amjpathol.orgof EdU on day 12 after bleomycin (2 days after AdId2). On
day 13, signiﬁcantly more EdU-positive cells were seen
within Id2-treated mice (Figure 2D). Costaining EdU with
prosurfactant protein-C, an AEC marker, and a-smooth
muscle actin, a myoﬁbroblast marker, demonstrated that
many of the proliferating cells were within AECs rather than
within myoﬁbroblasts (Figure 2, E and F). Collectively,
these results suggest that Id2 protects mice from bleomycin-
induced ﬁbrosis through suppressed AEC activation and
promoted AEC proliferation.
Id2 Attenuates AEC Collagen Production through Twist
Id2 is a class V HLH factor that dimerizes with basic HLH
transcription factor, inhibiting their activity.17 Several basic
HLH transcription factors have been implicated in mesen-
chymal gene expression in cancer cells, most notably Twist,
E2A (E47/E12), and E2-2. Ten days after IT bleomycin,
AECs were isolated and analyzed for expression of these
factors. We found most robust induction of Twist
(Figure 3A). Furthermore, AECs from uninjured mice1005
Figure 2 Overexpression of inhibitor of DNA-
binding 2 (Id2) protects mice from bleomycin
(Bleo)-induced ﬁbrosis. A and B: Trichrome sec-
tions of lungs after Bleo and adenovirus expressing
green ﬂuorescent protein (AdGFP; A) or AdId2 (B).
C: Hydroxyproline assay of whole lungs from mice
treated with saline or Bleo and AdGFP or AdId2.
Mice treated with AdId2 have an attenuated
response to Bleo. D: Mice treated with bleomycin
and AdId2 have increased numbers of 5-ethynyl-
20-deoxyuridine (EdU)epositive cells compared to
mice treated with Bleo and AdGFP. E and F: Lung
section from mouse treated with Bleo and AdId2
demonstrates EdU (red) staining in many surfac-
tant protein-C (SPC; green; E) positive AECs, but
not smooth muscle actin (SMA)epositive myoﬁ-
broblasts (green, F). n Z 5 to 8 (C); n Z 4 (D).
*P < 0.05 compared to AdGFP-treated mice.
Original magniﬁcations: 200 (A and B); 400
(E and F).
Yang et alcultured on Fn to induce TGFb1-mediated activation
in vitro also demonstrated robust induction of Twist. Inhi-
bition of TGFb1 signaling with 10 mmol/L TGFb receptor
inhibitor (SB431542) led to signiﬁcant reduction of Twist
expression (Figure 3B). To conﬁrm a direct interaction be-
tween Id2 and Twist, primary AECs were isolated, cultured
on Fn, and treated with AdGFP or AdId2 as before. After 4
days, cells were lysed and immunopreciptated for Id2,
demonstrating Twist coprecipitation in cells overexpressing
Id2 (Figure 3C). Finally, primary AECs from ﬂoxed Twist
mice were isolated and treated with AdGFP (control) or
adenovirus expressing Cre recombinase in vitro to eliminate
Twist expression. AECs with deleted Twist demonstrated
signiﬁcantly reduced expression of type I collagen similar to
cells overexpressing Id2 (Figure 3, D and E). Collectively,
these results indicate that Id2 suppression of AEC activation
is mediated through a direct inhibitory interaction with
Twist. However, mice with lung epithelial cellespeciﬁc
deletion of Twist were not protected from bleomycin-
induced ﬁbrosis (Supplemental Figure S3), suggesting that
Id2-mediated inhibition of Twist within AECs alone is
not sufﬁcient to block ﬁbrosis but may need to be in coor-
dination with other basic HLH factors or through concom-
itant induction of AEC proliferation.1006Id2 Induces Proliferation through an Rb-cAbl Axis
We then explored the mechanism of Id2-mediated prolif-
eration. Deletion of Twist within ﬂoxed Twist AECs did not
affect proliferation (data not shown).
Id2 proliferation has been linked to Rb in cancer cells, but
the mechanism remains poorly deﬁned.21,22 Rb acts as a
negative regulator of several proliferation pathways, most
prominently through regulation of E2F transcription factor.
However, overexpression of Id2 did not lead to increased E2F
activity (Figure 4, A and B) assessed by E2F-promoter lucif-
erase activation and expression of proliferating cell nuclear
antigen, a well-deﬁned E2F target involved in proliferation.44
Rb interaction and inhibitory effects on protein binding part-
ners can be regulated by distinct phosphorylation sites.45
AECs overexpressing Id2 were analyzed with Rb antibodies
recognizing phosphorylation at several distinct sites
(Figure 4C). Surprisingly, Id2 led to increased phosphoryla-
tion of Rb at serine 807/811 (S807/811), whereas Id2 did not
affect the phosphorylation of Rb at the other sites.
Mice were treated with IT bleomycin, AdId2, and EdU as
before. Lung sections were stained for EdU and pS807/811
Rb, demonstrating many co-positive cells (Figure 4, DeF),
indicating increased Rb phosphorylation at S807/811 withinajp.amjpathol.org - The American Journal of Pathology
Figure 3 Inhibitor of DNA-binding 2 (Id2)eTwist interaction regulates alveolar epithelial cell (AEC) activation. A: Expression of several basic helix-loop-
helix (HLH) transcription factors by AECs from mice 10 days after intratracheal (IT) saline or bleomycin immediately after isolation. B: Expression of basic HLH
factors by AECs immediately after isolation or after 4 days cultured on ﬁbronectin (Fn) with or without 10 mmol/L SB431642. Fn-cultured AECs undergo
transforming growth factor bedependent activation of Twist expression. C: Coimmunoprecipitation of Id2 and Twist in AECs cultured on Fn and treated with
adenovirus expressing Id2 (AdId2) or AdGFP. D and E: AECs from ﬂoxed Twist mice treated with adenovirus expressing Cre (AdCre) have reduced activation by
real-time quantitative PCR (D) and immunoblot (E). n Z 3 (A); n Z 4 (B and D). **P < 0.01 compared to AECs from saline-treated mice (A); *P < 0.05
compared to AECs cultured on Fn without SB431542, **P < 0.01 compared to AEC expression immediately after isolation (B), *P < 0.05 compared to AdGFP-
treated ﬂoxed Twist AECs (D). Col, collagen; CCN2, connective tissue growth factor; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
Id2 Prevents FibrosisId2-mediated proliferating AECs. Phosphorylation at S807/
811 has previously been shown to negatively regulate Rb
interaction with c-Abl kinase, which would be expected to
promote increased c-Abl activity.45 Indeed, overexpression of
Id2 led to dramatically decreased association between Rb and
c-Abl by coimmunoprecipitation (Figure 5A). Furthermore,The American Journal of Pathology - ajp.amjpathol.orgoverexpression of Id2 led to increased phosphorylation of
CrkL, a target of c-Abl, consistent with decreased Rb-
mediated inhibition of c-Abl activity (Figure 5B). c-Abl ac-
tivity is known to stimulate proliferation in several cell
types. AECs treated with two different c-Abl inhibitors,
10 mmol/L imatinib and 1 mmol/L nalotinib, had signiﬁcantlyFigure 4 Overexpression of inhibitor of DNA-
binding 2 (Id2) promotes retinoblastoma protein
(Rb) serine 807/811 phosphorylation by alveolar
epithelial cells (AECs). A: Overexpression of Id2
does not activate E2F response element luciferase
expression in AECs cultured on Matrigel. B: Over-
expression of Id2 does not affect expression of Rb
or proliferating cell nuclear antigen (PCNA) by
AECs. C: Immunoblot shows that AECs over-
expressing Id2 have increased Rb phosphorylation
at serine 807/811 (pS807/811). DeF: Lung sec-
tions from mice treated with bleomycin and AdId2
immunostained for 5-ethynyl-20-deoxyuridine
(green, D) and pS807/811 Rb (red, E) demonstrate
pS807/811 Rb within proliferating cells (F). Orig-
inal magniﬁcation, 200 (DeF).
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Figure 5 Inhibitor of DNA-binding 2 (Id2)einduced alveolar epithelial
cell (AEC) proliferation is mediated by retinoblastoma protein (Rb)/c-Abl
pathway. A: Rb coprecipitation with c-Abl is reduced in AECs over-
expressing Id2. B: AECs overexpressing Id2 have increased phosphorylation
of c-Abl target CrkL. C: cAbl kinase inhibitors imatinib (10 mmol/L) and
nalotinib (1 mmol/L) abrogate Id2-mediated AEC proliferation. n Z 4.
*P < 0.05 compared to control AECs overexpressing Id2 treated with
dimethyl sulfoxide. AdGFP, adenovirus expressing green ﬂuorescent pro-
tein; IP, immunoprecipitation.
Yang et alless Id2-mediated proliferation compared to AECs treated
with DMSO vehicle control, suggesting that Id2 mediates
AEC proliferation through a Rb-cAbl pathway (Figure 5C).Figure 6 Histone deacetylase (HDAC) inhibitors induce alveolar
epithelial cell (AEC) inhibitor of DNA-binding 2 (Id2) expression. A and B:
Green ﬂuorescent protein (GFP) expression by ﬂow cytometry of 96 wells of
Id2 promotereGFP AECs treated with different chemical compounds from a
library (A) indicating a well with GFP expression (B). C and D: HDAC in-
hibitors trichostatin A (TSA; 100 nmol/L) and MS275 (50 mmol/L) induce
Id2 expression (C) and suppress AEC ﬁbrotic matrix expression (D). n Z 4
(C and D). *P < 0.05 compared to AECs treated with dimethyl sulfoxide
(DMSO) alone. Col, collagen; Fn, ﬁbronectin.Histone Deacetylase Inhibition Induces Expression
of Id2
Id2 is highly expressed by epithelial progenitor cells during
embryonic lung development, but not by adult AECs.23 Id2
expression was not induced in adult AECs treated with bone
morphogenetic protein 4, bone morphogenetic protein 7, and
Wnt3, which induces Id2 in other cell types (data not shown).
We used AECs isolated from Id2 promotereGFP (Id2-GFP)
mice to identify compounds that might induce expression of Id2
in adult AECs. Id2-GFP AECs were cultured on Mg-coated
384-well plates and treated with a chemical compound library
(Supplemental Table S1). After 2 days, cells were trypsinized
and analyzed for GFP reporter expression by ﬂow cytometry
(Figure 6, A and B). Five compounds were found to induce
green ﬂuorescence: 6-aminoindazole, SB216763, RU24969,
MS275, and TSA. These compounds were then validated for
induction of Id2 expression by real-time quantitative PCR.
Three of the compounds (6-aminoindazole, SB216763,
and RU24969) did not induce expression of Id2 but were
found to induce green ﬂuorescence within treated AECs
(data not shown). Two other compounds, 50 mmol/L MS275
and 100 nmol/L TSA, induced robust expression of Id2
(Figure 6C) compared to AECs treated with DMSO vehicle
control. Both of these notably are histone deacetylase
(HDAC) inhibitors.
HDAC inhibitors have previously been shown to attenuate
ﬁbrosis and inhibit ﬁbroblast activation with suppression of1008type I collagen and a-smooth muscle actin, but the mechanism
remains poorly deﬁned.46,47 TSA andMS275 promoted robust
inhibition of collagen expression by primaryAECs cultured on
Fn (Figure 6D). Finally, primary AECs were treated with
lentivirus encoding shRNA to Id2 or scrambled shRNA and
HDAC inhibitors TSA and MS275. Inhibition of Id2 expres-
sion by shRNA led to partial reversal of the HDAC inhibitore
mediated suppression of collagen I expression (Figure 7, A
and B). AECs cultured on Mg were treated with lentivirus
encoding shRNA to Id2 and HDAC inhibitors. HDAC inhi-
bition led to decreased proliferation; however, decreased
expression of Id2 led to a much more robust inhibition ofajp.amjpathol.org - The American Journal of Pathology
Figure 7 Inhibitor of DNA-binding 2 (Id2)
shRNA partially reverses histone deacetylase (HDAC)
inhibitor effects on alveolar epithelial cells (AECs).
A and B: Real-time quantitative PCR mRNA expres-
sion of Id2 (A) and collagen I (B) by AECs treated
with 100 nmol/L trichostatin A (TSA), 50 mmol/L
MS275 (MS), or dimethyl sulfoxide (DMSO) control
(Ctrl) and lentivirus encoding shRNA to Id2 or
scrambled shRNA (10 plaque-forming units/cell). C:
Immunoblot for type I collagen by AECs treated
with TSA, MS275, or DMSO control and lentivirus
encoding shRNA to Id2 or scrambled shRNA. D: 3H-
thymidine incorporation proliferation assay of AECs
treated with TSA, MS275, or DMSO control and
lentivirus encoding shRNA to Id2 or scrambled
shRNA. E: Schematic of proposed mechanism. His-
tones inhibit expression of Id2. HDAC inhibitors TSA
and MS promote acetylated (Ac) histones that
disengage DNA and lead to increased expression of
Id2. Id2 binds to Twist, inhibiting collagen I
expression, and binds to phosphorylated (P) reti-
noblastoma protein (Rb), leading to c-Able
mediated proliferation. nZ 4 (B and D). *P < 0.05
compared to AECs treated with scrambled shRNA.
Col, collagen; GAPDH, glyceraldehyde-3-phosphate
dehydrogenase.
Id2 Prevents Fibrosisproliferation, suggesting that HDAC inhibitoremediated in-
duction of Id2 mitigates broader antiproliferative effects of
HDAC inhibitors (Figure 7, C and D).
Discussion
Our results demonstrate that Id2 regulates two major AEC
activities during the ﬁbrogenesis/repair process after injury
(Figure 7E). Our interest in Id2 stems from recent evidence
indicating a potential role for basic HLH transcription fac-
tors in ﬁbrosis. Id2 has mainly been studied in the context of
cancer, where it has been shown to induce proliferation and
inhibit invasion through suppressed mesenchymal gene
expression.12 Although these activities are potentially con-
founding in the context of cancer, both epithelial cell pro-
liferation and suppression of mesenchymal gene expression
may limit progression of ﬁbrosis.23 Id2 expression is high
within lung epithelial cells during development but is low
within adult AECs. As expected, IPF AECs had similar
levels of Id2 expression compared to normal human AECs.
However, overexpression of Id2 led to attenuated ﬁbrosis in
bleomycin-injured mice through enhanced AEC prolifera-
tion and inhibited AEC activation, suggesting that inducedThe American Journal of Pathology - ajp.amjpathol.orgreinitiation of Id2-mediated developmental programming
could shift the lung back toward normal homeostasis after
injury rather than ﬁbrosis.
Given their abundance, AEC activity after injury is likely
to be an important determinant of the extent of the resulting
ﬁbrosis. The balance of AEC apoptosis and proliferation is
one key determinant. Selective loss of lung epithelial cells is
sufﬁcient to induce ﬁbrosis, and stimulation of lung
epithelial cell proliferation has been shown to limit
ﬁbrosis.48,49 Several studies have shown that deletion of
genes involved in apoptosis protects mice from ﬁbrosis, but
strategies at promoting epithelial cell proliferation have not
been as well studied. It may be possible to moderately
augment epithelial cell proliferation after injury within the
bounds of normal cell cycle checkpoints to avoid malignant
transformation, but future studies will have to speciﬁcally
study this potential limitation.
Id2 has recently been shown to directly interact with Rb
and promote cancer cell proliferation.21,44 The immediate
downstream events of this interaction are not clear, but
focus has generally been on Rb as an inhibitor of prolifer-
ative effects of Id2. However, Rb acts as a direct inhibitor of
many different proteins involved in cell proliferation. We1009
Yang et alexplored the possibility that Id2 interaction limits Rb
inhibitory interaction with other proteins involved in pro-
liferation. We found that overexpression of Id2 promotes Rb
phosphorylation at S807/811. We conﬁrmed prior studies
that indicated that phosphorylation at S807/811 regulates Rb
interaction with c-Abl kinase. Imatinib, a c-Abl kinase in-
hibitor, was previously found to attenuate ﬁbrosis; however,
studies of its mechanism were limited primarily to ﬁbroblast
activation/proliferation, and the results of a clinical trial of
imatinib in patients with IPF were negative.34
The importance of epithelial-mesenchymal transcription
factors during ﬁbrosis has been previously reported. For
example, deletion of Snail within hepatocytes led to attenuated
liver ﬁbrosis50 and deletion of FoxM1 within AECs protected
mice from radiation-induced ﬁbrosis.51 Thus, targeting these
transcription factors for potential therapeutic intervention has
been of interest in cancer and, more recently, ﬁbrosis.
Although Twist is likely the most important target of Id2,
overexpression of Id2 attenuated ﬁbrosis, whereas mice with
AEC deletion of Twist developed ﬁbrosis after bleomycin,
suggesting that Id2 has broader antiﬁbrotic effects beyond
inhibition of Twist within AECs. These likely include effects
on other basic HLH transcription factors, such as E2A and E2-
2, which might compensate for loss of Twist and could also be
targets of Id2. These studies highlight the potential difﬁculties
with trying to suppress expression of a single transcription
factor. Furthermore, although a genetic approach demon-
strates the importance of these pathways in animal models,
actually targeting these transcription factors toward thera-
peutic intervention has been difﬁcult. In this regard, the basic
HLH transcription factors are appealing because of the po-
tential to use a natural inhibitory pathway. Thus, induction of
Id expression might be a way to limit proﬁbrotic transcrip-
tional activity of basic HLH factors during ﬁbrosis.
After ﬁnding that several factors that induce Id2 expres-
sion in other cell types did not inﬂuence Id2 expression
within adult AECs, we identiﬁed HDAC inhibitors as potent
inducers of Id2 expression using a library of chemical
compounds. HDAC inhibitors have previously been shown
to attenuate ﬁbrosis in several animal models and to block
ﬁbroblast expression of ﬁbrotic matrix proteins.46,47 How-
ever, the mechanism by which HDAC inhibition affects
ﬁbrosis remains poorly characterized. Histone deacetylation
is generally thought to repress gene expression, whereas
HDAC inhibition would be expected to promote gene
expression. Thus, suppressed type I collagen expression by
ﬁbroblasts in response to HDAC inhibitors suggests the
induced expression of a transcriptional repressor, such as Id
family members. HDAC inhibitors likely inﬂuence the
expression of many genes, and our studies demonstrate that
induced expression of Id2 only partially accounts for the
effects of HDAC inhibitors on AEC behavior. Future
studies could be directed at inhibition of a more targeted
HDAC. Finally, identiﬁcation and conﬁrmation of HDAC
inhibitors as inducers of Id2 expression validates our screen
approach, and in future studies we will expand our screen to1010identify other compounds that might more speciﬁcally
induce Id2 expression.
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